Burkhart Erin 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Apr 12, 2024
Insider Transaction Report
Form 4
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-04-10$90.00/sh−2,286$205,740→ 16,156 total
Footnotes (1)
- [F1]Trade made pursuant to a 10b5-1 plan executed on November 29, 2023.